On the other hand, Li et al. uncovered that both LINC00665 and its micro-peptide CIP2A-BP contribute to the progression of hepatocellular carcinoma by enhancing cancer cell growth and motility [37]. Here, CIP2A is linked to hepatocellular carcinoma.